Skip to main content

REVIEW article

Front. Pharmacol.

Sec. Neuropharmacology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1425560

The critical role of Sirt1 in ischemic stroke

Provisionally accepted
Ziyi Jia Ziyi Jia 1Ke Xu Ke Xu 2Ruobing Li Ruobing Li 1Siyu Yang Siyu Yang 2Long Chen Long Chen 3Qianwen Zhang Qianwen Zhang 1Shulin Li Shulin Li 4*XiaoWei Sun XiaoWei Sun 4*
  • 1 Heilongjiang University of Chinese Medicine first clinical School, Harbin, China
  • 2 Heilongjiang University of Chinese Medicine Second Clinical School, Harbin, China
  • 3 The Fourth Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China
  • 4 First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province, China

The final, formatted version of the article will be published soon.

    Ischemic stroke, the most prevalent form of stroke, is responsible for the highest disability rates globally and ranks as the primary cause of mortality worldwide. Sirt1, extensively investigated in neurodegenerative disorders, is the most well-known and earliest member of the sirtuins family.However, its mechanism of action during ischemic stroke remains ambiguous. The literature examination revealed the intricate involvement of Sirt1 in regulating both physiological and pathological mechanisms during ischemic stroke. Sirt1 demonstrates deacetylation effects on PGC-1 α, HMGB1, FOXOs, and p53. It hinders the activation of NLRP3 inflammasome and NF-κB while also engaging with AMPK. It regulates inflammatory response, oxidative stress, mitochondrial dysfunction, autophagy, pro-death, and necrotic apoptosis. Therefore, the potential of Sirt1 as a therapeutic target for the management of ischemic stroke is promising.

    Keywords: ischemic stroke, SIRT1, Inflammation, Oxidative Stress, Autophagy, Mitochondrial dysfunction, Pan-apoptosis

    Received: 30 Apr 2024; Accepted: 25 Feb 2025.

    Copyright: © 2025 Jia, Xu, Li, Yang, Chen, Zhang, Li and Sun. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Shulin Li, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province, China
    XiaoWei Sun, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more